ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Exploring the presence of DFG-funded publications in Naunyn-Schmiedeberg's Archives of Pharmacology.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A bibliometric study of the most-cited research articles and reviews in Naunyn-Schmiedeberg's Archives of Pharmacology (1969-2024).Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Country-specific citation disparities in Naunyn-Schmiedeberg's Archives of Pharmacology from 2001 to 2024.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The primary objective of this study is to analyze the number of Deutsche Forschungsgemeinschaft (DFG)-sponsored papers published in Naunyn-Schmiedeberg's Archives of Pharmacology (NSAP), the oldest pharmacology journal in the world. This is the first systematic investigation of DFG-sponsored research in NSAP. Using the Scopus database, which provides comprehensive citation data from 1969 onward (for NSAP), the study identifies DFG-sponsored publications in the fields of pharmacology, toxicology, and pharmaceutics. The analysis includes only peer-reviewed articles and reviews, excluding other document types such as conference proceedings or editorials etc. The results show that, out of 453,047 total DFG-sponsored publications from 1969 to the present, only 3.05% (13,847) are in the specialized fields of pharmacology, toxicology, and pharmaceutics. This is relatively low compared to other research areas such as biochemistry, genetics, and molecular biology (24.69%), and physics and astronomy (23.37%). The study further analyzes the yearly publication dynamics of DFG-sponsored papers in NSAP, revealing a concerning trend: between 2015 and 2023, fewer than 10 DFG-sponsored papers were published in each of these years, with the lowest being 2 publications in 2022. These findings raise questions regarding the visibility and contribution of DFG-funded research in NSAP and suggest that strategies could be developed to enhance the presence of DFG-sponsored research in this historically significant journal. The study does not aim to interfere with funding policies but encourages a discussion on ways to improve publication outcomes for DFG-sponsored projects, particularly in well-established journals like NSAP. Collaboration between researchers, universities, and funding bodies may be key to promoting the visibility and impact of DFG-funded research in relevant academic journals.
Indexed as
Identifiers
40343451What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.